Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 2 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Intraoperative Complications 1 Inflammatory Bowel Diseases 1 Diverticulitis 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Arrhythmias, Cardiac 1 Anesthesia 1

Interventions

Sunitinib 86 Sorafenib 60 Everolimus 47 pazopanib 46 Bevacizumab 46 Nivolumab 44 pembrolizumab 37 aldesleukin 29 Interferon-alpha 26 Axitinib 24 temsirolimus 23 cabozantinib 20 Interleukin-2 19 Ipilimumab 16 Interferon alpha-2 15 Cyclophosphamide 15 fludarabine phosphate 14 Gemcitabine 14 Peripheral Blood Stem Cell Transplantation 11 Sirolimus 10 Paclitaxel 10 Erlotinib Hydrochloride 10 avelumab 8 Radiosurgery 8 Docetaxel 8 Cyclosporine 8 Capecitabine 8 tremelimumab 7 lenvatinib 7 Mycophenolic Acid 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Renal Cell × Anesthesia, Epidural × Clear all

NCT02030717 2015-06-04

ASA

Umeå University

Phase 2/3 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡